What question did this study set out to answer?

Investigate the role of regulatory T cells (Tregs) in immune evasion and therapeutic resistance in lung cancer.

May 22, 2026Molecular CancerOpen Access

The Treg-cell death axis in lung cancer: implications for immune evasion and novel therapeutic strategies

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial explores Treg influence on immune responses in lung cancer, suggesting new therapeutic approaches.

Investigate the role of regulatory T cells (Tregs) in immune evasion and therapeutic resistance in lung cancer.
Focused on the dynamics of Treg survival and death in the tumor microenvironment (TME).
Analyzed tumor-derived factors that support Treg persistence and immune suppression.
Proposed mechanisms for targeting Tregs to enhance therapeutic responses.
Tregs significantly suppress antitumor immune responses in the TME, limiting the effectiveness of immune checkpoint inhibitors.
Enhanced Treg survival correlates with resistance to cell death, reducing effector T cell functionality.
Targeting Tregs shows potential to improve immune responses against tumors, indicating new treatment avenues.

Fan et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark